NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.34
-0.32 (-2.34%)
At close: Mar 27, 2026, 4:00 PM EDT
13.33
-0.01 (-0.07%)
After-hours: Mar 27, 2026, 4:10 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $448.78 million as of March 27, 2026. Its market cap has increased by 32.15% in one year.
Market Cap
448.78M
Enterprise Value
458.56M
1-Year Change
32.15%
Ranking
Category
Stock Price
$13.34
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $448.78M, an increase of 14.11%. That is a compound annual growth rate of 2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 448.78M | -12.73% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytek Biosciences | 588.76M |
| SI-BONE | 567.08M |
| Axogen | 559.20M |
| Beta Bionics | 511.28M |
| Perspective Therapeutics | 480.80M |
| Orthofix Medical | 473.30M |
| Varex Imaging | 451.68M |
| OrthoPediatrics | 413.31M |